SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001833141-23-000008
Filing Date
2023-08-14
Accepted
2023-08-14 07:39:39
Documents
9
Period of Report
2023-08-14

Document Format Files

Seq Description Document Type Size
1 6-K cybininc-form6xkq1x24.htm 6-K 16433
2 EX-99.1 cybinincfs-q1x24xjune302023.htm EX-99.1 444914
3 EX-99.2 cybin-mdaxq1x24xjune302023.htm EX-99.2 746735
4 EX-99.3 q12024-cfocertificatecybin.htm EX-99.3 12758
5 EX-99.4 q12024-ceocertificatecybin.htm EX-99.4 12780
6 EX-99.5 a08-14x2023xq12024xearning.htm EX-99.5 36680
7 GRAPHIC cybinlogo2023.jpg GRAPHIC 10741
8 GRAPHIC cybinlogo2023a.jpg GRAPHIC 10741
9 GRAPHIC image_0.jpg GRAPHIC 13600
  Complete submission text file 0001833141-23-000008.txt   1320067
Mailing Address 100 KING STREET WEST SUITE 5600 TORONTO A6 M5X 1C9
Business Address 100 KING STREET WEST SUITE 5600 TORONTO A6 M5X 1C9 (908) 764-8385
CYBIN INC. (Filer) CIK: 0001833141 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A6 | Fiscal Year End: 0331
Type: 6-K | Act: 34 | File No.: 001-40673 | Film No.: 231166304
SIC: 2834 Pharmaceutical Preparations